141 related articles for article (PubMed ID: 9643364)
1. Identification of a heparin-binding domain in the distal carboxyl-terminal region of lipoprotein lipase by site-directed mutagenesis.
Sendak RA; Bensadoun A
J Lipid Res; 1998 Jun; 39(6):1310-5. PubMed ID: 9643364
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of a putative heparin binding domain of avian lipoprotein lipase.
Berryman DE; Bensadoun A
J Biol Chem; 1993 Feb; 268(5):3272-6. PubMed ID: 8429005
[TBL] [Abstract][Full Text] [Related]
3. Binding of hepatic lipase to heparin. Identification of specific heparin-binding residues in two distinct positive charge clusters.
Sendak RA; Berryman DE; Gellman G; Melford K; Bensadoun A
J Lipid Res; 2000 Feb; 41(2):260-8. PubMed ID: 10681410
[TBL] [Abstract][Full Text] [Related]
4. Identification of the epitope of a monoclonal antibody that inhibits heparin binding of lipoprotein lipase: new evidence for a carboxyl-terminal heparin-binding domain.
Sendak RA; Melford K; Kao A; Bensadoun A
J Lipid Res; 1998 Mar; 39(3):633-46. PubMed ID: 9548595
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase.
Ma Y; Henderson HE; Liu MS; Zhang H; Forsythe IJ; Clarke-Lewis I; Hayden MR; Brunzell JD
J Lipid Res; 1994 Nov; 35(11):2049-59. PubMed ID: 7868983
[TBL] [Abstract][Full Text] [Related]
6. The mutant Asn291-->Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin.
Buscà R; Peinado J; Vilella E; Auwerx J; Deeb SS; Vilaró S; Reina M
FEBS Lett; 1995 Jul; 367(3):257-62. PubMed ID: 7607318
[TBL] [Abstract][Full Text] [Related]
7. Segments in the C-terminal folding domain of lipoprotein lipase important for binding to the low density lipoprotein receptor-related protein and to heparan sulfate proteoglycans.
Nielsen MS; Brejning J; García R; Zhang H; Hayden MR; Vilaró S; Gliemann J
J Biol Chem; 1997 Feb; 272(9):5821-7. PubMed ID: 9038197
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein lipaseBethesda: a single amino acid substitution (Ala-176----Thr) leads to abnormal heparin binding and loss of enzymic activity.
Beg OU; Meng MS; Skarlatos SI; Previato L; Brunzell JD; Brewer HB; Fojo SS
Proc Natl Acad Sci U S A; 1990 May; 87(9):3474-8. PubMed ID: 2110364
[TBL] [Abstract][Full Text] [Related]
9. Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9-->Asn, Tyr262-->His).
Rouis M; Lohse P; Dugi KA; Lohse P; Beg OU; Ronan R; Talley GD; Brunzell JD; Santamarina-Fojo S
J Lipid Res; 1996 Mar; 37(3):651-61. PubMed ID: 8728326
[TBL] [Abstract][Full Text] [Related]
10. Structural features in lipoprotein lipase necessary for the mediation of lipoprotein uptake into cells.
Krapp A; Zhang H; Ginzinger D; Liu MS; Lindberg A; Olivecrona G; Hayden MR; Beisiegel U
J Lipid Res; 1995 Nov; 36(11):2362-73. PubMed ID: 8656074
[TBL] [Abstract][Full Text] [Related]
11. An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells.
Sivaram P; Choi SY; Curtiss LK; Goldberg IJ
J Biol Chem; 1994 Apr; 269(13):9409-12. PubMed ID: 8144523
[TBL] [Abstract][Full Text] [Related]
12. Subdomain chimeras of hepatic lipase and lipoprotein lipase. Localization of heparin and cofactor binding.
Hill JS; Yang D; Nikazy J; Curtiss LK; Sparrow JT; Wong H
J Biol Chem; 1998 Nov; 273(47):30979-84. PubMed ID: 9812994
[TBL] [Abstract][Full Text] [Related]
13. Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain.
Hata A; Ridinger DN; Sutherland S; Emi M; Shuhua Z; Myers RL; Ren K; Cheng T; Inoue I; Wilson DE
J Biol Chem; 1993 Apr; 268(12):8447-57. PubMed ID: 8473288
[TBL] [Abstract][Full Text] [Related]
14. Molecular modeling of the dimeric structure of human lipoprotein lipase and functional studies of the carboxyl-terminal domain.
Kobayashi Y; Nakajima T; Inoue I
Eur J Biochem; 2002 Sep; 269(18):4701-10. PubMed ID: 12230584
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate proteoglycans are primarily responsible for the maintenance of enzyme activity, binding, and degradation of lipoprotein lipase in Chinese hamster ovary cells.
Berryman DE; Bensadoun A
J Biol Chem; 1995 Oct; 270(41):24525-31. PubMed ID: 7592670
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein lipase domain function.
Wong H; Davis RC; Thuren T; Goers JW; Nikazy J; Waite M; Schotz MC
J Biol Chem; 1994 Apr; 269(14):10319-23. PubMed ID: 8144612
[TBL] [Abstract][Full Text] [Related]
17. The mutation Gly142-->Glu in human lipoprotein lipase produces a missorted protein that is diverted to lysosomes.
Buscà R; Martínez M; Vilella E; Pognonec P; Deeb S; Auwerx J; Reina M; Vilaró S
J Biol Chem; 1996 Jan; 271(4):2139-46. PubMed ID: 8567671
[TBL] [Abstract][Full Text] [Related]
18. The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity.
Sandström J; Carlsson L; Marklund SL; Edlund T
J Biol Chem; 1992 Sep; 267(25):18205-9. PubMed ID: 1517248
[TBL] [Abstract][Full Text] [Related]
19. Functional topology of a surface loop shielding the catalytic center in lipoprotein lipase.
Faustinella F; Smith LC; Chan L
Biochemistry; 1992 Aug; 31(32):7219-23. PubMed ID: 1510914
[TBL] [Abstract][Full Text] [Related]
20. Chimeras of hepatic lipase and lipoprotein lipase. Domain localization of enzyme-specific properties.
Davis RC; Wong H; Nikazy J; Wang K; Han Q; Schotz MC
J Biol Chem; 1992 Oct; 267(30):21499-504. PubMed ID: 1400461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
